Spectral Medical Provides April Tigris Trial Update
06 mai 2024 07h30 HE
|
Spectral Medical Inc.
• 105 patients enrolled • April represents a record breaking month for patient enrollment TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:...
Spectral Medical Provides Tigris Trial Update
10 avr. 2024 07h00 HE
|
Spectral Medical Inc.
101 patients enrolled TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...
Spectral Medical Chair to Retire From the Board of Directors
02 avr. 2024 08h00 HE
|
Spectral Medical Inc.
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update
28 mars 2024 16h00 HE
|
Spectral Medical Inc.
TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Provides February Tigris Trial Update
28 févr. 2024 07h30 HE
|
Spectral Medical Inc.
93 patients enrolledFebruary represents a second record breaking consecutive month for patient enrollment TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
21 févr. 2024 16h00 HE
|
Spectral Medical Inc.
TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients
15 févr. 2024 07h41 HE
|
Spectral Medical Inc.
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Provides Early February Tigris Trial Update
05 févr. 2024 07h30 HE
|
Spectral Medical Inc.
88 patients enrolled January being the highest enrollment month since the launch of Tigris TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...
Spectral Medical Provides January Tigris Trial Update
30 janv. 2024 07h30 HE
|
Spectral Medical Inc.
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Enrolls Patient 82 in Its Phase 3 FDA Tigris Septic Shock Trial
10 janv. 2024 07h00 HE
|
Spectral Medical Inc.
New patient enrollment sites accelerating screening activityScreening activity exceeding 100 patients per weekApproaching interim enrollment target of 90 patients TORONTO, Jan. 10, 2024 (GLOBE...